Ignite Creation Date:
2024-05-06 @ 8:20 PM
Last Modification Date:
2024-10-26 @ 3:26 PM
Study NCT ID:
NCT06349837
Status:
RECRUITING
Last Update Posted:
2024-04-05
First Post:
2024-03-31
Brief Title:
Safety and Tolerability of LDRT Plus Concurrent Partial SBRT and Tislelizumab in Patients With Bulky Tumors
Sponsor:
Sichuan University
Organization:
Sichuan University
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-04-15
Start Date Type:
ESTIMATED
Primary Completion Date:
2025-03-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-03-31
Completion Date Type:
ESTIMATED
First Submit Date:
2024-03-31
First Submit QC Date:
April 4 2024
Study First Post Date:
2024-04-05
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-08-22
Last Update Post Date:
2024-04-05
Last Update Post Date Type:
ACTUAL